China expands HPV vaccination
China has integrated the bivalent HPV vaccine into its national immunization program, offering free doses to girls aged 13 and older. This move aims to combat the country's high rates of cervical cancer by improving vaccine accessibility.
Why it matters
Expanding access to HPV vaccines is a critical public health intervention that can significantly reduce cervical cancer mortality rates globally.
Bluesky LinkedIn Vaccines China Bivalent human papillomavirus (HPV) vaccine is now included in the country’s national immunization program (NIP), ensuring girls across China can access this essential tool for preventing cervical cancer.
The article focuses on public health policy and medical data, maintaining a neutral and informative tone.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in